Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction

Padraig G. O'neill, Martin L. Charlat, Han Seob Kim, Jennifer Pocius, Lloyd H. Michael, Craig J. Hartley, Wei Xi Zhu, Robert Roberts, Roberto Bolli

Research output: Contribution to journalArticle

Abstract

Summary: The role of lipoxygenase activation in the genesis of postischaemic myocardial dysfunction was investigated in open chest dogs undergoing a 15 min occlusion of the left anterior descending artery followed by 4 h of reperfusion. Treated animals (n=9) received nafazatrom, a potent lipoxygenase inhibitor, 10 mg·kg-1 orally 4 h before occlusion followed by intravenous boluses of 1.5 mg·kg-1 and 0.5 mg·kg-1 5 min before occlusion and 1 min before reperfusion respectively. Control animals (n=10) received saline. No discernible haemodynamic effects were produced by the drug. Collateral flow to the ischaemic zone (radioactive microspheres) was 0.14(0.02) ml·min-1·g-1 in the control group and 0.16(0.05) ml·min-1·g-1 in the treated group. The size of the occluded bed as determined by postmortem perfusion was 25.5(0.8)% of the left ventricle in the control and 24.3(1.3)% in the treated group. Histological examination showed a decrease in neutrophil infiltration of the non-ischaemic myocardium and, to a lesser extent, of the reperfused myocardium in nafazatrom treated animals, suggesting lipoxygenase inhibition. Systolic wall thickening (an index of regional function) was assessed using an epicardial pulsed Doppler probe. The two groups exhibited comparable systolic thickening under baseline conditions. Though treated animals showed less dyskinesis during coronary occlusion (p

Original languageEnglish (US)
Pages (from-to)755-760
Number of pages6
JournalCardiovascular Research
Volume21
Issue number10
DOIs
StatePublished - Oct 1987
Externally publishedYes

Fingerprint

Ventricular Dysfunction
Lipoxygenase Inhibitors
Occlusion
Inhibitor
Animals
Reperfusion
Lipoxygenase
Myocardium
Hospital Bed Capacity
Neutrophils
Microspheres
Left Ventricle
Infiltration
Neutrophil Infiltration
Coronary Occlusion
Hemodynamics
Arteries
Doppler
Heart Ventricles
Activation

Keywords

  • Lipoxygenase
  • Nafazatrom
  • Postischaemic ventricular dysfunction

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

O'neill, P. G., Charlat, M. L., Kim, H. S., Pocius, J., Michael, L. H., Hartley, C. J., ... Bolli, R. (1987). Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction. Cardiovascular Research, 21(10), 755-760. https://doi.org/10.1093/cvrese/21.10.755

Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction. / O'neill, Padraig G.; Charlat, Martin L.; Kim, Han Seob; Pocius, Jennifer; Michael, Lloyd H.; Hartley, Craig J.; Zhu, Wei Xi; Roberts, Robert; Bolli, Roberto.

In: Cardiovascular Research, Vol. 21, No. 10, 10.1987, p. 755-760.

Research output: Contribution to journalArticle

O'neill, PG, Charlat, ML, Kim, HS, Pocius, J, Michael, LH, Hartley, CJ, Zhu, WX, Roberts, R & Bolli, R 1987, 'Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction', Cardiovascular Research, vol. 21, no. 10, pp. 755-760. https://doi.org/10.1093/cvrese/21.10.755
O'neill, Padraig G. ; Charlat, Martin L. ; Kim, Han Seob ; Pocius, Jennifer ; Michael, Lloyd H. ; Hartley, Craig J. ; Zhu, Wei Xi ; Roberts, Robert ; Bolli, Roberto. / Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction. In: Cardiovascular Research. 1987 ; Vol. 21, No. 10. pp. 755-760.
@article{d0fa7de0342741daa6a9af70476a7530,
title = "Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction",
abstract = "Summary: The role of lipoxygenase activation in the genesis of postischaemic myocardial dysfunction was investigated in open chest dogs undergoing a 15 min occlusion of the left anterior descending artery followed by 4 h of reperfusion. Treated animals (n=9) received nafazatrom, a potent lipoxygenase inhibitor, 10 mg·kg-1 orally 4 h before occlusion followed by intravenous boluses of 1.5 mg·kg-1 and 0.5 mg·kg-1 5 min before occlusion and 1 min before reperfusion respectively. Control animals (n=10) received saline. No discernible haemodynamic effects were produced by the drug. Collateral flow to the ischaemic zone (radioactive microspheres) was 0.14(0.02) ml·min-1·g-1 in the control group and 0.16(0.05) ml·min-1·g-1 in the treated group. The size of the occluded bed as determined by postmortem perfusion was 25.5(0.8){\%} of the left ventricle in the control and 24.3(1.3){\%} in the treated group. Histological examination showed a decrease in neutrophil infiltration of the non-ischaemic myocardium and, to a lesser extent, of the reperfused myocardium in nafazatrom treated animals, suggesting lipoxygenase inhibition. Systolic wall thickening (an index of regional function) was assessed using an epicardial pulsed Doppler probe. The two groups exhibited comparable systolic thickening under baseline conditions. Though treated animals showed less dyskinesis during coronary occlusion (p",
keywords = "Lipoxygenase, Nafazatrom, Postischaemic ventricular dysfunction",
author = "O'neill, {Padraig G.} and Charlat, {Martin L.} and Kim, {Han Seob} and Jennifer Pocius and Michael, {Lloyd H.} and Hartley, {Craig J.} and Zhu, {Wei Xi} and Robert Roberts and Roberto Bolli",
year = "1987",
month = "10",
doi = "10.1093/cvrese/21.10.755",
language = "English (US)",
volume = "21",
pages = "755--760",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction

AU - O'neill, Padraig G.

AU - Charlat, Martin L.

AU - Kim, Han Seob

AU - Pocius, Jennifer

AU - Michael, Lloyd H.

AU - Hartley, Craig J.

AU - Zhu, Wei Xi

AU - Roberts, Robert

AU - Bolli, Roberto

PY - 1987/10

Y1 - 1987/10

N2 - Summary: The role of lipoxygenase activation in the genesis of postischaemic myocardial dysfunction was investigated in open chest dogs undergoing a 15 min occlusion of the left anterior descending artery followed by 4 h of reperfusion. Treated animals (n=9) received nafazatrom, a potent lipoxygenase inhibitor, 10 mg·kg-1 orally 4 h before occlusion followed by intravenous boluses of 1.5 mg·kg-1 and 0.5 mg·kg-1 5 min before occlusion and 1 min before reperfusion respectively. Control animals (n=10) received saline. No discernible haemodynamic effects were produced by the drug. Collateral flow to the ischaemic zone (radioactive microspheres) was 0.14(0.02) ml·min-1·g-1 in the control group and 0.16(0.05) ml·min-1·g-1 in the treated group. The size of the occluded bed as determined by postmortem perfusion was 25.5(0.8)% of the left ventricle in the control and 24.3(1.3)% in the treated group. Histological examination showed a decrease in neutrophil infiltration of the non-ischaemic myocardium and, to a lesser extent, of the reperfused myocardium in nafazatrom treated animals, suggesting lipoxygenase inhibition. Systolic wall thickening (an index of regional function) was assessed using an epicardial pulsed Doppler probe. The two groups exhibited comparable systolic thickening under baseline conditions. Though treated animals showed less dyskinesis during coronary occlusion (p

AB - Summary: The role of lipoxygenase activation in the genesis of postischaemic myocardial dysfunction was investigated in open chest dogs undergoing a 15 min occlusion of the left anterior descending artery followed by 4 h of reperfusion. Treated animals (n=9) received nafazatrom, a potent lipoxygenase inhibitor, 10 mg·kg-1 orally 4 h before occlusion followed by intravenous boluses of 1.5 mg·kg-1 and 0.5 mg·kg-1 5 min before occlusion and 1 min before reperfusion respectively. Control animals (n=10) received saline. No discernible haemodynamic effects were produced by the drug. Collateral flow to the ischaemic zone (radioactive microspheres) was 0.14(0.02) ml·min-1·g-1 in the control group and 0.16(0.05) ml·min-1·g-1 in the treated group. The size of the occluded bed as determined by postmortem perfusion was 25.5(0.8)% of the left ventricle in the control and 24.3(1.3)% in the treated group. Histological examination showed a decrease in neutrophil infiltration of the non-ischaemic myocardium and, to a lesser extent, of the reperfused myocardium in nafazatrom treated animals, suggesting lipoxygenase inhibition. Systolic wall thickening (an index of regional function) was assessed using an epicardial pulsed Doppler probe. The two groups exhibited comparable systolic thickening under baseline conditions. Though treated animals showed less dyskinesis during coronary occlusion (p

KW - Lipoxygenase

KW - Nafazatrom

KW - Postischaemic ventricular dysfunction

UR - http://www.scopus.com/inward/record.url?scp=0023637812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023637812&partnerID=8YFLogxK

U2 - 10.1093/cvrese/21.10.755

DO - 10.1093/cvrese/21.10.755

M3 - Article

C2 - 3125975

VL - 21

SP - 755

EP - 760

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 10

ER -